Corrigendum to: Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK-3β-dependent β-catenin/Wnt pathway activation (FEBS Journal, (2014), 281, 23, (5371-5389), 10.1111/febs.13081);Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK-3β-dependent β-catenin/Wnt pathway activation

FEBS Journal

Volumn 281, Issue 23, 2014, Pages 5371-5389

  Zhu, Zhenzhong ^a   Yin, Junhui ^a   Guan, Junjie ^a   Hu, Bin ^a   Niu, Xin ^a   Jin, Dongxu ^a   Wang, Yang ^a   Zhang, Changqing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Glycogen synthase kinase 3 ; Lithium; Mesenchymal stem cells; Proliferation; Wnt signal transduction pathway

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; BETA CATENIN; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; QUERCETIN; SMALL INTERFERING RNA; CTNNB1 PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ADULT; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PROTEIN PHOSPHORYLATION; WNT SIGNALING PATHWAY; BONE MARROW CELL; CELL CULTURE; DRUG EFFECTS; MESENCHYMAL STROMA CELL; PHYSIOLOGY;

BETA CATENIN; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LITHIUM; MESENCHYMAL STROMAL CELLS; WNT SIGNALING PATHWAY;

EID: 84918830274     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.15827     Document Type: Erratum

References (76)

1. Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE & Brenner MK (2001) Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97, 1227-1231.
2. Koga H, Muneta T, Nagase T, Nimura A, Ju YJ, Mochizuki T & Sekiya I (2008) Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res 333, 207-215.
3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S & Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
4. Dixon JA, Gorman RC, Stroud RE, Bouges S, Hirotsugu H, Gorman JH 3rd, Martens TP, Itescu S, Schuster MD, Plappert T et al. (2009) Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation 120, S220-S229.
5. Gu W, Zhang F, Xue Q, Ma Z, Lu P & Yu B (2010) Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord. Neuropathology 30, 205-217.
6. Kim HJ, Lee JH & Kim SH (2010) Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis. J Neurotrauma 27, 131-138.
7. Joyce N, Annett G, Wirthlin L, Olson S, Bauer G & Nolta JA (2010) Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 5, 933-946.
8. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49.
9. Friedewald VE, Hare JM, Miller LW, Walpole HT Jr, Willerson JT & Roberts WC (2012) The editor's roundtable: advances in stem cell therapy for treatment of cardiovascular disease. Am J Cardiol 110, 807-816.
10. Trivedi P, Tray N, Nguyen T, Nigam N & Gallicano GI (2010) Mesenchymal stem cell therapy for treatment of cardiovascular disease: helping people sooner or later. Stem Cells Dev 19, 1109-1120.
11. Zhang YH, Wang HF, Liu W, Wei B, Bing LJ & Gao YM (2009) Insulin-producing cells derived from rat bone marrow and their autologous transplantation in the duodenal wall for treating diabetes. Anat Rec 292, 728-735.
12. Chanda D, Kumar S & Ponnazhagan S (2010) Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. J Cell Biochem 111, 249-257.
13. Young W (2009) Review of lithium effects on brain and blood. Cell Transplant 18, 951-975.
14. Jim RT (1979) Leukocytosis: side effect of lithium. Blood 53, 1031.
15. Stein RS, Flexner JM & Graber SE (1979) Lithium and granulocytopenia during induction therapy of acute myelogenous leukemia. Blood 54, 636-641.
16. Stein RS, Beaman C, Ali MY, Hansen R, Jenkins DD & Jume'an HG (1977) Lithium carbonate attenuation of chemotherapy-induced neutropenia. N Engl J Med 297, 430-431.
17. Meisler AI (1977) Lithium carbonate in chemotherapyinduced neutropenia. N Engl J Med 297, 1179-1180.
18. Zhu Z, Kremer P, Tadmori I, Ren Y, Sun D, He X & Young W (2011) Lithium suppresses astrogliogenesis by neural stem and progenitor cells by inhibiting STAT3 pathway independently of glycogen synthase kinase 3 beta. PLoS One 6, e23341.
19. Kim JS, Chang MY, Yu IT, Kim JH, Lee SH, Lee YS & Son H (2004) Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo. J Neurochem 89, 324-336.
20. Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N & Manji HK (2000) Enhancement of hippocampal neurogenesis by lithium. J Neurochem 75, 1729-1734.
21. van Eijsden P, Notenboom RG, Wu O, de Graan PN, van Nieuwenhuizen O, Nicolay K & Braun KP (2004) In vivo 1H magnetic resonance spectroscopy, T2-weighted and diffusion-weighted MRI during lithiumpilocarpine-induced status epilepticus in the rat. Brain Res 1030, 11-18.
22. Su H, Chu TH & Wu W (2007) Lithium enhances proliferation and neuronal differentiation of neural progenitor cells in vitro and after transplantation into the adult rat spinal cord. Exp Neurol 206, 296-307.
23. Gu Z, Tan W, Feng G, Meng Y, Shen B, Liu H & Cheng C (2014) Wnt/beta-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway. Mol Cell Biochem 387, 27-37.
24. Arend RC, Londono-Joshi AI, Straughn JM Jr & Buchsbaum DJ (2013) The Wnt/beta-catenin pathway in ovarian cancer: a review. Gynecol Oncol 131, 772-779.
25. Neth P, Ciccarella M, Egea V, Hoelters J, Jochum M & Ries C (2006) Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. Stem cells 24, 1892-1903.
26. Wexler EM, Geschwind DH & Palmer TD (2008) Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry 13, 285-292.
27. Gregory CA, Perry AS, Reyes E, Conley A, Gunn WG & Prockop DJ (2005) Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow. J Biol Chem 280, 2309-2323.
28. Zhang R, Oyajobi BO, Harris SE, Chen D, Tsao C, Deng HW & Zhao M (2013) Wnt/beta-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 52, 145-156.
29. Jullien N, Maudinet A, Leloutre B, Ringe J, Haupl T & Marie PJ (2012) Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cells. J Cell Biochem 113, 2047-2056.
30. Du Y, Ling J, Wei X, Ning Y, Xie N, Gu H & Yang F (2012) Wnt/beta-catenin signaling participates in cementoblast/osteoblast differentiation of dental follicle cells. Connect Tissue Res 53, 390-397.
31. De Boer J, Wang HJ & Van Blitterswijk C (2004) Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng 10, 393-401.
32. Satija NK, Sharma D, Afrin F, Tripathi RP & Gangenahalli G (2013) High throughput transcriptome profiling of lithium stimulated human mesenchymal stem cells reveals priming towards osteoblastic lineage. PLoS One 8, e55769.
33. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R & Ben-Ze'ev A (1999) The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96, 5522-5527.
34. Tsai LK, Wang Z, Munasinghe J, Leng Y, Leeds P & Chuang DM (2011) Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model. Stroke 42, 2932-2939.
35. Jope RS (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24, 441-443.
36. Clement-Lacroix P, Ai M, Morvan F, Roman-Roman S, Vayssiere B, Belleville C, Estrera K, Warman ML, Baron R & Rawadi G (2005) Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice. Proc Natl Acad Sci USA 102, 17406-17411.
37. Baghaban Eslaminejad M, Karimi N & Shahhoseini M (2011) Enhancement of glycosaminoglycan-rich matrix production in human marrow-derived mesenchymal stem cell chondrogenic culture by lithium chloride and SB216763 treatment. Cell J 13, 117-126.
38. Galceran J, Miyashita-Lin EM, Devaney E, Rubenstein JL & Grosschedl R (2000) Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. Development 127, 469-482.
39. Park CH, Chang JY, Hahm ER, Park S, Kim HK & Yang CH (2005) Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun 328, 227-234.
40. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B & Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512.
41. Kuroda R, Ishida K, Matsumoto T, Akisue T, Fujioka H, Mizuno K, Ohgushi H, Wakitani S & Kurosaka M (2007) Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthr Cartil 15, 226-231.
42. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N & Yoneda M (2002) Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartil 10, 199-206.
43. Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y & Horibe S (2004) Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant 13, 595-600.
44. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW et al. (2005) Cotransplantation of HLAidentical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11, 389-398.
45. Gaebel R, Ma N, Liu J, Guan J, Koch L, Klopsch C, Gruene M, Toelk A, Wang W, Mark P et al. (2011) Patterning human stem cells and endothelial cells with laser printing for cardiac regeneration. Biomaterials 32, 9218-9230.
46. Mojsilovic S, Krstic A, Ilic V, Okic-Dordevic I, Kocic J, Trivanovic D, Santibanez JF, Jovcic G & Bugarski D (2011) IL-17 and FGF signaling involved in mouse mesenchymal stem cell proliferation. Cell Tissue Res 346, 305-316.
47. You DH & Nam MJ (2013) Effects of human epidermal growth factor gene-transfected mesenchymal stem cells on fibroblast migration and proliferation. Cell Prolif 46, 408-415.
48. Weiner ML, Batt KJ, Putman DL, Curren RD & Yang LL (1990) Genotoxicity evaluation of lithium hypochlorite. Toxicology 65, 1-22.
49. Gould TD, Gray NA & Manji HK (2003) Effects of a glycogen synthase kinase-3 inhibitor, lithium, in adenomatous polyposis coli mutant mice. Pharmacol Res 48, 49-53.
50. Schmidt MM, Guan K & Wobus AM (2001) Lithium influences differentiation and tissue-specific gene expression of mouse embryonic stem (ES) cells in vitro. Int J Dev Biol 45, 421-429.
51. Sato N, Meijer L, Skaltsounis L, Greengard P & Brivanlou AH (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK- 3-specific inhibitor. Nat Med 10, 55-63.
52. Thomson JA & Ludwig T (2013) Culture medium containing gamma-aminobutyric acid, pipecolic acid or lithium for the maintenance of stem cells in an undifferentiated state in, Google Patents.
53. Wood AJ, Goodwin GM, De Souza R & Green AR (1986) The pharmacokinetic profile of lithium in rat and mouse; an important factor in psychopharmacological investigation of the drug. Neuropharmacology 25, 1285-1288.
54. Netto I & Phutane VH (2012) Reversible lithium neurotoxicity: review of the literatur. Prim Care Companion CNS Disord 14, doi: 10.4088/PCC.11r01197.
55. Kemperman CJ, Gerdes JH, De Rooij J & Vencken LM (1989) Reversible lithium neurotoxicity at normal serum level may refer to intracranial pathology. J Neurol Neurosurg Psychiatry 52, 679-680.
56. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O & Woodgett JR (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406, 86-90.
57. Gomez-Sintes R, Hernandez F, Bortolozzi A, Artigas F, Avila J, Zaratin P, Gotteland JP & Lucas JJ (2007) Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice. EMBO J 26, 2743-2754.
58. Sproule B (2002) Lithium in bipolar disorder: can drug concentrations predict therapeutic effect? Clin Pharmacokinet 41, 639-660.
59. Ebadi MS, Simmons VJ, Hendrickson MJ & Lacy PS (1974) Pharmacokinetics of lithium and its regional distribution in rat brain. Eur J Pharmacol 27, 324-329.
60. Schou M (1958) Lithium studies. 3. Distribution between serum and tissues. Acta Pharmacol Toxicol 15, 115-124.
61. Takada I, Kouzmenko AP & Kato S (2009) Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 5, 442-447.
62. Chen Y & Alman BA (2009) Wnt pathway, an essential role in bone regeneration. J Cell Biochem 106, 353-362.
63. Westendorf JJ, Kahler RA & Schroeder TM (2004) Wnt signaling in osteoblasts and bone diseases. Gene 341, 19-39.
64. Krishnan V, Bryant HU & Macdougald OA (2006) Regulation of bone mass by Wnt signaling. J Clin Investig 116, 1202-1209.
65. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA & Ornitz DM (2003) Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130, 3063-3074.
66. Arioka M, Takahashi-Yanaga F, Sasaki M, Yoshihara T, Morimoto S, Takashima A, Mori Y & Sasaguri T (2013) Acceleration of bone development and regeneration through the Wnt/beta-catenin signaling pathway in mice heterozygously deficient for GSK-3beta. Biochem Biophys Res Commun 440, 677-682.
67. Caldwell GM, Jones CE, Soon Y, Warrack R, Morton DG & Matthews GM (2008) Reorganisation of Wntresponse pathways in colorectal tumorigenesis. Br J Cancer 98, 1437-1442.
68. Le Floch N, Rivat C, De Wever O, Bruyneel E, Mareel M, Dale T & Gespach C (2005) The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3beta and c-Jun/AP-1 signaling. FASEB J 19, 144-146.
69. Merdek KD, Nguyen NT & Toksoz D (2004) Distinct activities of the alpha-catenin family, alpha-catulin and alpha-catenin, on beta-catenin-mediated signaling. Mol Cell Biol 24, 2410-2422.
70. Kulkarni NH, Onyia JE, Zeng Q, Tian X, Liu M, Halladay DL, Frolik CA, Engler T, Wei T, Kriauciunas A et al. (2006) Orally bioavailable GSK- 3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. J Bone Miner Res 21, 910-920.
71. Smith E, Coetzee GA & Frenkel B (2002) Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta. J Biol Chem 277, 18191-18197.
72. Tan G, Kang PD & Pei FX (2012) Glucocorticoids affect the metabolism of bone marrow stromal cells and lead to osteonecrosis of the femoral head: a review. Chin Med J (Engl) 125, 134-139.
73. Soleimani M & Nadri S (2009) A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 4, 102-106.
74. Etheridge SL, Spencer GJ, Heath DJ & Genever PG (2004) Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem cells 22, 849-860.
75. Lin P, Chang H, Tsai WT, Wu MH, Liao YS, Chen JT & Su JM (2003) Overexpression of aryl hydrocarbon receptor in human lung carcinomas. Toxicol Pathol 31, 22-30.
76. Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, Sakamoto D, Caothien RH, Fuller JH, Reinhard C et al. (2001) Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta-catenin signaling is activated in human colon tumors. Proc Natl Acad Sci USA 98, 14973-14978.